Related Experiment Video
Updated: Jul 24, 2026

06:02
2-Methacryloyloxyethyl Phosphorylcholine Polymer Treatment of Complete Dentures to Inhibit Denture Plaque Deposition
Published on: December 26, 2016
10.9K
Randomized Trial of Plaque-Identifying Toothpaste: Decreasing Plaque and Inflammation
Kim Fasula1, Carla A Evans1, Linda Boyd2
1College of Dentistry, University of Illinois at Chicago, Boston.
The American Journal of Medicine
|October 25, 2016
Summary
A new plaque-identifying toothpaste significantly reduced dental plaque and high-sensitivity C-reactive protein (hs-CRP), a marker for cardiovascular disease. This suggests potential benefits for reducing cardiovascular disease risk.
Area of Science:
- Oral hygiene research
- Cardiovascular disease biomarkers
- Inflammation markers
Background:
- Limited data exist on plaque-identifying toothpastes' effects on dental plaque and inflammation.
- Inflammation, measured by hs-CRP, is crucial in atherosclerosis and cardiovascular disease (CVD) pathogenesis.
Purpose of the Study:
- To test if Plaque HD toothpaste reduces dental plaque and hs-CRP levels.
- To evaluate the plaque-identifying toothpaste's impact on inflammation markers.
Main Methods:
- A randomized trial involving 61 healthy adults aged 19-44 years.
- Participants used either plaque-identifying or placebo toothpaste for 60 days.
- Assessed changes in dental plaque and hs-CRP from baseline.
Main Results:
- Plaque-identifying toothpaste reduced mean plaque score by 49% vs. 24% for placebo (P=.001).
- In subjects with elevated hs-CRP, plaque-identifying toothpaste reduced hs-CRP by 29% vs. a 25% increase with placebo (P=.041).
Conclusions:
- Plaque-identifying toothpaste significantly reduced both dental plaque and hs-CRP.
- Findings support the hypothesis that this toothpaste may reduce cardiovascular disease risk.
- Further large-scale trials are needed to confirm CVD risk reduction.
Keywords:
Plaque HDPlaque-identifying toothpasteReducing dental plaqueReducing hs-CRPReducing inflammationMore Related Videos
Related Concept Videos
Inflammation
Overview
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

